Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AT25
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0003723 | RNA binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 69 | 73 | PF00656 | 0.551 |
CLV_NRD_NRD_1 | 139 | 141 | PF00675 | 0.557 |
CLV_NRD_NRD_1 | 255 | 257 | PF00675 | 0.579 |
CLV_NRD_NRD_1 | 47 | 49 | PF00675 | 0.435 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.507 |
CLV_PCSK_FUR_1 | 92 | 96 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 139 | 141 | PF00082 | 0.575 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.459 |
CLV_PCSK_KEX2_1 | 47 | 49 | PF00082 | 0.435 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.433 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.505 |
CLV_PCSK_PC1ET2_1 | 139 | 141 | PF00082 | 0.592 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.459 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.433 |
CLV_PCSK_PC1ET2_1 | 94 | 96 | PF00082 | 0.593 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.549 |
CLV_Separin_Metazoa | 210 | 214 | PF03568 | 0.602 |
CLV_Separin_Metazoa | 23 | 27 | PF03568 | 0.598 |
DEG_APCC_DBOX_1 | 5 | 13 | PF00400 | 0.444 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.523 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.535 |
DOC_USP7_MATH_1 | 233 | 237 | PF00917 | 0.772 |
DOC_USP7_MATH_1 | 32 | 36 | PF00917 | 0.568 |
DOC_USP7_UBL2_3 | 253 | 257 | PF12436 | 0.589 |
DOC_USP7_UBL2_3 | 269 | 273 | PF12436 | 0.535 |
DOC_WW_Pin1_4 | 28 | 33 | PF00397 | 0.553 |
LIG_Actin_WH2_2 | 56 | 73 | PF00022 | 0.551 |
LIG_BIR_III_4 | 41 | 45 | PF00653 | 0.452 |
LIG_deltaCOP1_diTrp_1 | 107 | 117 | PF00928 | 0.513 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.440 |
LIG_FHA_2 | 250 | 256 | PF00498 | 0.614 |
LIG_LIR_Apic_2 | 73 | 79 | PF02991 | 0.548 |
LIG_LIR_Gen_1 | 46 | 57 | PF02991 | 0.569 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.570 |
LIG_PROFILIN_1 | 243 | 249 | PF00235 | 0.762 |
LIG_SH2_CRK | 142 | 146 | PF00017 | 0.513 |
LIG_SH2_NCK_1 | 142 | 146 | PF00017 | 0.489 |
LIG_SH2_NCK_1 | 76 | 80 | PF00017 | 0.553 |
LIG_SH2_SRC | 166 | 169 | PF00017 | 0.741 |
LIG_SH2_SRC | 76 | 79 | PF00017 | 0.556 |
LIG_SH2_SRC | 88 | 91 | PF00017 | 0.631 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.489 |
LIG_SH2_STAP1 | 84 | 88 | PF00017 | 0.580 |
LIG_SH3_2 | 248 | 253 | PF14604 | 0.622 |
LIG_SH3_3 | 238 | 244 | PF00018 | 0.665 |
LIG_SH3_3 | 245 | 251 | PF00018 | 0.601 |
LIG_SUMO_SIM_par_1 | 59 | 66 | PF11976 | 0.533 |
LIG_TRAF2_1 | 252 | 255 | PF00917 | 0.592 |
LIG_WW_3 | 210 | 214 | PF00397 | 0.488 |
MOD_CK1_1 | 229 | 235 | PF00069 | 0.776 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.473 |
MOD_CK2_1 | 249 | 255 | PF00069 | 0.619 |
MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.703 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.645 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.456 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.559 |
MOD_GSK3_1 | 229 | 236 | PF00069 | 0.766 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.534 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.534 |
MOD_N-GLC_1 | 26 | 31 | PF02516 | 0.502 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.523 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.476 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.551 |
MOD_PIKK_1 | 233 | 239 | PF00454 | 0.571 |
MOD_PKA_1 | 256 | 262 | PF00069 | 0.570 |
MOD_PKA_2 | 212 | 218 | PF00069 | 0.625 |
MOD_PKA_2 | 229 | 235 | PF00069 | 0.771 |
MOD_PKA_2 | 70 | 76 | PF00069 | 0.555 |
MOD_Plk_1 | 71 | 77 | PF00069 | 0.519 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.555 |
MOD_ProDKin_1 | 28 | 34 | PF00069 | 0.558 |
MOD_SUMO_rev_2 | 254 | 259 | PF00179 | 0.563 |
MOD_SUMO_rev_2 | 37 | 46 | PF00179 | 0.533 |
TRG_DiLeu_BaEn_1 | 20 | 25 | PF01217 | 0.542 |
TRG_DiLeu_BaEn_4 | 101 | 107 | PF01217 | 0.561 |
TRG_ENDOCYTIC_2 | 142 | 145 | PF00928 | 0.470 |
TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.392 |
TRG_ER_diArg_1 | 114 | 117 | PF00400 | 0.584 |
TRG_ER_diArg_1 | 25 | 28 | PF00400 | 0.462 |
TRG_ER_diArg_1 | 47 | 49 | PF00400 | 0.455 |
TRG_ER_diArg_1 | 92 | 95 | PF00400 | 0.509 |
TRG_ER_diLys_1 | 269 | 274 | PF00400 | 0.627 |
TRG_Pf-PMV_PEXEL_1 | 10 | 14 | PF00026 | 0.523 |
TRG_Pf-PMV_PEXEL_1 | 19 | 23 | PF00026 | 0.386 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HXA6 | Leptomonas seymouri | 63% | 98% |
A0A0S4JT72 | Bodo saltans | 41% | 100% |
A0A3Q8IJE0 | Leishmania donovani | 86% | 100% |
A0A422NCV8 | Trypanosoma rangeli | 44% | 99% |
A4HPB4 | Leishmania braziliensis | 82% | 100% |
A4ICF4 | Leishmania infantum | 86% | 100% |
D0A3C3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
Q4Q1H3 | Leishmania major | 86% | 95% |
V5D8K3 | Trypanosoma cruzi | 45% | 100% |